BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28068245)

  • 1. Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer.
    Pucci S; Polidoro C; Joubert A; Mastrangeli F; Tolu B; Benassi M; Fiaschetti V; Greco L; Miceli R; Floris R; Novelli G; Orlandi A; Santoni R
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):381-388. PubMed ID: 28068245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rab5C enhances resistance to ionizing radiation in rectal cancer.
    Baptistella AR; Landemberger MC; Dias MVS; Giudice FS; Rodrigues BR; da Silva PPCE; Cassinela EK; Lacerda TC; Marchi FA; Leme AFP; Begnami MD; Aguiar S; Martins VR
    J Mol Med (Berl); 2019 Jun; 97(6):855-869. PubMed ID: 30968159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Koyama FC; Lopes Ramos CM; Ledesma F; Alves VAF; Fernandes JM; Vailati BB; São Julião GP; Habr-Gama A; Gama-Rodrigues J; Perez RO; Camargo AA
    Br J Surg; 2018 Jan; 105(2):e192-e203. PubMed ID: 29341150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
    Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
    J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
    Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression.
    Pucci S; Mazzarelli P; Sesti F; Boothman DA; Spagnoli LG
    Cell Cycle; 2009 Feb; 8(3):473-81. PubMed ID: 19177010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Sathyakumar K; Chandramohan A; Masih D; Jesudasan MR; Pulimood A; Eapen A
    Br J Radiol; 2016; 89(1060):20150328. PubMed ID: 26828967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
    Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of percent change in tumoral volume measured at T
    Quaia E; Gennari AG; Ricciardi MC; Ulcigrai V; Angileri R; Cova MA
    J Magn Reson Imaging; 2016 Dec; 44(6):1415-1424. PubMed ID: 27219471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.
    Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY
    Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.
    Casado E; Garcia VM; Sánchez JJ; Gómez Del Pulgar MT; Feliu J; Maurel J; Castelo B; Moreno Rubio J; López RA; García-Cabezas MÁ; Burgos E; de Castro J; Belda-Iniesta C; López-Gómez M; Gómez-Raposo C; Zambrana F; Sereno M; Fernández-Martos C; Vázquez P; Lacal JC; González-Barón M; Cejas P
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1151-8. PubMed ID: 22516806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
    Liu H; Zhang Z; Zhen P; Zhou M
    J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
    Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
    Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study.
    Genovesi D; Filippone A; Ausili Cèfaro G; Trignani M; Vinciguerra A; Augurio A; Di Tommaso M; Borzillo V; Sabatino F; Innocenti P; Liberatore E; Colecchia G; Tartaro A; Cotroneo AR
    Eur J Surg Oncol; 2013 Oct; 39(10):1071-8. PubMed ID: 23953231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.